GLP1R and type 2 diabetes mellitus: A recent meta-analysis of eight randomized trials showed that compared to placebo, GLP-1 receptor agonist significantly improved biopsy resolution in patients with T2DM and NAFLD, in addition to biochemical markers of liver function [120].